Missing weekly cisplatin cycles was associated with worse overall survival in patients with head and neck cancers, particularly for those with p16-negative tumors. @OSUCCC_James @JAMANetworkOpen @JAMAOnc #hncsm #MedTwitter
#hncsm #MedTwitter